Enrique Zudaire
SVP TR Caribou Biosciences
Seminars
Tuesday 8th December 2026
Ensuring Consistent Donor Material Characterization to Strengthen Clinical-Stage Cell Therapy Development
9:30 am
- Standardizing donor screening criteria to reduce variability and improve starting material consistency across clinical manufacturing campaigns
- Implementing robust donor characterization assays to strengthen comparability between batches and support reliable clinical outcomes
- Establishing fit-for-purpose quality control frameworks to identify variability early and maintain product consistency throughout development
